Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Enzyme Activity Assay from US Patent US12030897: "Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof"
Assay data:15 Active, 15 Activity ≤ 1 µM, 15 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
BTK Kinase Assay from US Patent US20240217973: "IMIDAZOPYRIDINE COMPOUNDS AND USE THEREOF"
Assay data:12 Active, 1 Activity ≤ 1 nM, 12 Activity ≤ 1 µM, 12 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Biochemical Assay from US Patent US20240182487: "MACROCYCLES AND THEIR USE"
Assay data:40 Active, 3 Activity ≤ 1 nM, 40 Activity ≤ 1 µM, 42 Tested
Biological Assay from US Patent US20240182466: "A Crystal Form of a Fluorine-substituted Pyridopyrazole Compound and a Preparation Method Thereof"
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
HTRF-Based EGFR Biochemical Assay from US Patent US20240166665: "COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF"
Assay data:2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibitory Activity Assay from US Patent US11976059: "Isoindolin-1-on derivative, method for preparing same, and pharmaceutical composition comprising same as effective component for preventing or treating cancer"
Assay data:63 Active, 47 Activity ≤ 1 µM, 71 Tested
ITK Enzyme Assay from US Patent US20240124439: "Pyrido[2,3-D]Imidazole Derivatives and Their Use As Inhibitors of ITK for the Treatment of Skin Disease"
Assay data:119 Active, 116 Activity ≤ 1 µM, 119 Tested
Kinetic Labeling Experiments of Ibrutinib Derivatives with BTK from US Patent US20240139326: "METHACRYLAMIDES PROTEIN BINDERS AND USES THEREOF"
Assay data:10 Active, 8 Activity ≤ 1 nM, 10 Activity ≤ 1 µM, 10 Tested
ITK Enzyme Assay from US Patent US20240132477: "Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease"
Assay data:40 Active, 40 Activity ≤ 1 µM, 40 Tested
Electrophoretic Mobility Shift Assay (MSA) from US Patent US20240109877: "PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE"
Assay data:19 Active, 19 Activity ≤ 1 nM, 19 Activity ≤ 1 µM, 19 Tested
In Vitro BTK Kinase Assay: Btk-PolyGAT-LS Assay from US Patent US20240083900: "PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS"
Assay data:228 Active, 80 Activity ≤ 1 nM, 228 Activity ≤ 1 µM, 228 Tested
EGFR Kinase Assay from US Patent US20240083857: "2-Methyl-Quinazolines"
Assay data:5 Active, 2 Activity ≤ 1 µM, 301 Tested
TBD from US Patent US20240059694: "COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOF"
Assay data:30 Active, 30 Activity ≤ 1 µM, 30 Tested
BTK(h) Study from US Patent US20240051955: "4-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOF"
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
TBD from US Patent US20240034743: "TRICYCLIC COMPOUNDS AS EGFR INHIBITORS"
Assay data:135 Active, 118 Activity ≤ 1 nM, 137 Activity ≤ 1 µM, 137 Tested
Assay data:133 Active, 31 Activity ≤ 1 nM, 137 Activity ≤ 1 µM, 137 Tested
Protein Tyrosine Kinase, EGF Receptor Eurofins Panlabs panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
ITK Invitrogen Lab (UK) kinase screen (BI)
EGFR Invitrogen Lab (UK) kinase screen (BI)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on